HOME >> BIOLOGY >> NEWS
Smoking gun for Alzheimer's disease

In a world first, Australian researchers have found a toxin that plays an important role in the progression of Alzheimer's disease (AD), the most common cause of dementia.

The research is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing. At present, there are only minimally effective treatments for the condition, which is increasing with the ageing population.

"We found that all of the brains of dementia patients showed quinolinic acid neurotoxicity," said Professor Bruce Brew, Director of Neurology at St Vincent's Hospital and Professor of Medicine at the University of New South Wales (UNSW). "This acid kills nerve cells in the brain, leading to brain dysfunction and ultimately death."

There are currently more than 200, 000 people with Alzheimer's disease in Australia. The number will exceed 730, 000 by 2050.

"Quinolinic acid is part of a biochemical pathway called the kynurenine pathway," said the lead author of the research, UNSW's Dr Gilles Guillemin, who is based at the Centre for Immunology at St Vincent's Hospital. "The activation of that pathway is also found in other major brain diseases including Huntington's disease, stroke, dementia and schizophrenia."

The paper Indoleamine 2, 3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus has been published this week in the leading international journal Neuropathology and Applied Neurobiology. It is the result of collaboration between researchers from St Vincent's Hospital, UNSW, the University of Sydney and Hokkaido University, Japan.

"There are several drugs which can block this pathway, which are already under investigation by our laboratory and others," said Dr Guillemin.

The drugs, which would need to be tested for efficacy, could be used to complement other treatments.

"Quinolinic acid may
'"/>

Contact: Susi Hamilton
susi.hamilton@unsw.edu.au
61-2-9385-1583
Research Australia
4-Aug-2005


Page: 1 2

Related biology news :

1. Smoking produces changes in human brain like those in animals using illicit drugs
2. Smoking increases risk and omega-3 fatty acids decreases risk of blinding disease
3. Smoking interferes with brains recovery from alcoholism
4. Smoking damages key regulatory enzyme in the lung
5. Smoking is in the genes
6. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
7. Link identified between Alzheimers disease and glaucoma
8. UCF research links proteins, stem cells and potential Alzheimers treatment
9. Journal of Alzheimers Disease achieves significant impact factor
10. Alzheimers prevention role discovered for prions
11. Cloned pigs help scientists towards a breakthrough in Alzheimers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: